P0816 : Reduction in annual medical costs with early treatment of HCV using AbbVie 3D (ABT-450/ritonavir/ombitasvir and dasabuvir) +/− ribavirin in the United States.

Authors :: Misurski, D.A.
Johnson, S.J.
Samp, J.C.
Marx, S.E.
Juday, T.R.
Virabhak, S.
Parisé, H.
Saab, S.
Source :: Journal of Hepatology. Apr2015 Supplement 2, Vol. 62, pS642-S642. 1p.
Publication Year :: 2015

Subjects :: *HEPATITIS C treatment
*HEPATITIS C virus
*RITONAVIR
*CARBAMATES
*RIBAVIRIN
*MEDICAL care costs
*THERAPEUTICS

Full Text Access

Tools